Nano Flow’s Anti-IMP gold conjugate is based on a monoclonal antibody targeting IMP-type metallo-beta-lactamase (IMP), an important antimicrobial resistance marker in Gram-negative bacteria. Validated as a detection antibody in lateral flow assays, it enables highly specific and reproducible detection of IMP-producing strains. The corresponding capture antibody is also available, providing developers with a complete antibody pair for rapid and reliable diagnostic test development.
Anti-IMP Gold Conjugate – 40 nm (Ref NF-IMP-AU)
This conjugate shows no cross-reactivity with other carbapenemases, ensuring diagnostic accuracy in antimicrobial resistance testing. Produced on Nano Flow’s highly spherical 40 nm gold nanoparticles (OD20), it guarantees reproducibility, stability, and strong visual signal intensity across assay formats.
Applications: Lateral flow assays (LF) and other immunoassay platforms for antimicrobial resistance diagnostics.
Certificate of Analysis: Supplied with each batch, including TEM, DLS, and UV-Vis characterization.
Technical Specifications
| Parameter | Specification |
|---|---|
| Antibody format | IgG1 |
| Host | Mouse |
| Clonality | Monoclonal |
| Specificity | IMP-type metallo-beta-lactamase (IMP) |
| Cross-reactivity | None with other carbapenemases |
| Gold nanoparticle size | 40 nm |
| Concentration of the gold conjugate | OD20 |
| Buffer | Borate, BSA 0.25%, NaN₃ 0.09%, pH 7.3 |
| Shelf life | 1 year |
| Available volumes | From 1 ml to 1 L+ |
